The events calendar is for in-person industry events. Please do not post online events to the event calendar.
Jump to a month:
- December 2016
- January 2017
- February 2017
- March 2017
- April 2017
- May 2017
- June 2017
- September 2017
- November 2017
December 5-6, 2016
The Desmond Hotel and Conference Center, Malvern, PA, United States
The course consists of interactive lectures, discussions, and imbedded exercises. Participants will also be placed in several real life situations where they complete a compliance review of a schematic process flow diagram, analyze failures using trend reports, critique a risk assessment, and perform a change control analysis including the impact of requested or proposed modifications. The course is designed to provide the attendee with a practical understanding of the following topics: •Basic water chemistry •Water quality selection criteria •EPA, EU, and WHO drinking water standards •The governing regulatory agencies with direct impact on water systems •Analytical water grades (1, 2, 3) and reagent water types (I, II, III, IV, with A, B & C subgroups) •Pharmacopeia water grades (Purified, Highly Purified, Water for Injection & Clean Steam) •Pretreatment component equipment - selection and operating principals •Final treatment options (reverse osmosis, vapor compression, single-effect and multiple-effect stills) •Opportunities for energy and water resource conservation •Point of use criteria such as temperature, location, time-of-day, and demand (GPM & GPD) •System design including materials of construction, generation, storage and distribution options •Trend reports (analysis, problem identification, predictive value) •Control systems, data historian, secure access, set points and alarms •Managing performance deviations and component failure •Direct and in-direct impact analysis •Quality by design including risk assessment •Instrument calibration for critical, non-critical, and informational only devices •Maintenance impacts to system performance, reliability, and validation •The importance of as-built documentation - user and field directed changes
December 5-6, 2016
Sheraton Philadelphia University Center, Philadelphia, PA, United States
This year, the event will take an in-depth look at methodologies and how metrics can be used to improve clinical performance throughout a trial. Using case studies from across the industry, panels of thought leaders and pioneers, and presentations from academics and practitioners, ExL has built a program that can be applied and internalized. A few of our favorite sessions include: Find Tools and Data to Focus on Measuring with Meaning with Austin Allan, Senior Director RandD Quality Processes and Systems, ALEXION PHARMACEUTICALS CASE STUDY: Pfizer’s Study Quality Risk Model with Jonathan Rowe, Executive Director, Head of Quality Performance Management, and Alex Hsieh, Director, Clinical Trial Process and Quality, PFIZER The Association of Clinical Research Professionals' Efforts to Improve Clinical Quality Across the Industry with Jim Kremidas, Executive Director, ASSOCIATION of CLINICAL RESEARCH ASSOCIATES
December 5-7, 2016
InterContinental Mark Hopkins, San Franciso, CA, United States
From understanding potential supply constraints to implementing new and emerging technologies, this conference will bring together experts and leaders to ensure the Biomanufacturing industry successfully navigates this growth period and delivers on our promise of supply of life changing medicines to patients across the globe. Topics include: New paradigms for manufacturing capacity Getting more out of existing infrastructure Large/small scale demand Emerging technologies in biologics, and more! Register by 4 November and Save!
December 6-7, 2016
Amba Hotel Marble Arch, London, Non-U.S., United Kingdom
While publication of the Clinical Trial Database is delayed, the endorsement of the Clinical Trial Regulation is moving forward in other areas. The Clinical Trials Forum will focus on the differences between, the present and new requirements on managing clinical trials in the face of forthcoming changes. This 2-day workshop will provide a forum for information exchange on both conceptual and practical questions of: - How will the new legislation change the processes and the format of the trial application? - What are the impacts on how a clinical trial is managed after approval has been granted? - What are the critical issues affecting sponsors and Member States as they consider changes needed to implement the regulation? - How will the new provisions for public access to an EU Clinical Trials Database enforce disclosure of clinical trial data and information? Attendees will participate in the collaborative discussions through lectures, panel discussions and interactive sessions. Learning objectives - Understand the new requirements along with the practical and operational considerations for implementation by authorities and clinical trial sponsors - Identify the key challenges and opportunities of the new requirements and policies - Leverage insights on how companies and research institutions are fine-tuning and optimising - processes to meet the requirements of the Clinical Trials Regulation - Exchange views between regulators, clinical trial sponsors, patients, and other stakeholders The course is suitable for people working in the pharmaceutical industry and contract research organisations, from clinical science and clinical operations Monitors, auditors of clinical trials, Regulatory affairs personnel, and Pharmacovigilance staff.
December 6-7, 2016
Venue to be announced shortly, Sydney, Non-U.S., Australia
This program will cover the requirements for laboratory controls under US GMP regulations and compare them to those applied by other international health regulatory authorities. Laboratory controls relating to equipment calibration and preventive maintenance; sample chain of custody; good documentation practices; investigation of out of specification and out of trend results; analytical method validation; change control; impact of staffing levels and work flow patterns in the lab on GMP compliance; training and other issues will be included under laboratory controls.
December 7-8, 2016
Manchester Grand Hyatt , San Diego, CA, United States
The 2016 PDA Data Integrity Workshop, offered several times in global locations, will explore the multiple facets of data integrity, such as quality culture, human behavior, training needs and technology requirements. Through case studies, presentations and breakout sessions, this interactive, must-attend event will help you learn implementable, best practices for preventing, detecting, mitigating and remediating data integrity issues.
December 7-8, 2016
Amba Hotel Marble Arch, London, Non-U.S., United Kingdom
Transparency of clinical trial information is taking on new dimensions, including the release of anonymized participant-level data and return of results to study participants. Clinical trial sponsors and academia are facing a host of new registration requirements in the EU and the US. There is a call to share their clinical trial data and industry's initiatives on data sharing are also expanding. This increased transparency and use of information from clinical trials brings with it new data use opportunities and operational challenges for industry and academia. The continuing expansion of disclosure requirements in the US and EU leave many sponsors and academia considering disclosure strategy, developing operational measures, and looking for efficient ways to manage dissemination of clinical trial protocol information and results data. The users of clinical trial information is varied which provides both opportunities and challenges for how the information is provided. Learning objectives Learn about the latest developments relating to the EU Clinical Trial Regulation and its impact on transparency, and trends in the global clinical trial disclosure world Benefit from the various perspectives on clinical trial transparency of large, mid-sized, and smaller sponsor organizations Leverage best practices on implementation of clinical trial disclosure through case studies by exchanging views between regulators, industry, patients, academia and other stakeholders
December 7-9, 2016
The Desmond Hotel and Concerence Center, Malvern, PA, United States
This is a three-day course designed to provide individuals with an in depth understanding of the design, balancing, commissioning, operation and maintenance of HVAC systems in a regulated environment. The course consists of lectures and imbedded exercises. Participants will also be placed in several real life situations such as completing a compliance review of floor plans and air flow diagrams, room pressurization schemes, ductwork design, and air balance reports; conducting emergency egress analysis during a system failure; HVAC risk assessment; and change control analysis including the impact of modifications requested by the end user. The course is designed to provide the attendee with thorough knowledge of the following topics: •The governing regulatory agencies with direct impact on HVAC systems •FDA and EU classified space comparison •What constitutes Good Engineering Practice •The major components of an HVAC system •A high level overview of Psychrometrics •The engineering and design process •Latent and sensible loads •Types of systems – application and operation •Energy conservation measures and their impact on system performance •Ventilation requirements •Control set points and alarms •Air balancing – cascading air flows and room pressurization •Risk assessment for HVAC •Air filtration – from bird screens to terminal HEPA filters •Sources of air particle contamination •Room air-change rates – ISO standards •Room recovery period versus air change rates •Sterility versus containment •Humidity and temperature set points – range of control and tolerances •Instrument calibration – critical, non-critical, and informational •Maintenance impacts to system performance, reliability, and validation •Partnering with the system owner to obtain funding for major repairs, upgrades or wholesale replacement •Personnel safety and egress considerations •The importance of as-built documentation – user and field directed changes •The engineering turnover package (ETOP) and commissioning
Understanding the Statistical Considerations for Quantitative ICH Guidelines: 2-Day Hands-on Workshop
December 8-9, 2016
Venue to be announced shortly, San Francisco, CA, United States
Course Description: This course is designed to introduce to individuals the understanding and interpretation of the statistical concepts with reference to certain quantitative ICH Guidelines that apply across laboratory (drug development) and clinical development (drug/device) procedures such as analytical methods in validation and acceptance criteria in calibration procedures, risk management and process monitoring as well as dealing with uncertainties and other relevant issues. It is not a course in statistics but introduces the participant to a hands on approach to the statistical techniques one uses, how they are applied and reasonably interpreted and understood. One will address the various challenges facing pharmaceutical and biotechnology companies when it comes to quantifying results in a meaningful interpretable manner through tabulations and graphical presentations. In this two day workshop seminar one will learn the different regulatory agencies expectations of the quantification and development of a sound statistical monitoring of process control that are accepted, effective, and efficient. Participants will become familiar with the important aspects of the statistical methods and learn how organizations are expected to apply these guidelines.
December 12-13, 2016
Hilton San Diego Resort and Spa, San Diego, CA, United States
The Bioproduction Summit delves deep into the world of biological production. Here you'll find solutions to the most critical challenges in RandD, upstream, downstream and manufacturing excellence. Industry gurus, technology leaders and innovating academics will deliver the latest thinking on how to increase yields, meet regulations and reduce costs. Key topics on the agenda include purification, single use systems, tech transfer, ADCs, PAT, biosimilars, automation, continuous processing, lean and cell culture technologies. This summit is for you if you are interested in... Creating hybrid facilities of the future by balancing the costs and benefits of stainless and disposable systems Keeping costs down and guaranteeing quality by incorporating the latest technologies Ensuring compliance with the latest ever evolving regulations Moving towards continuous manufacturing by bringing downstream up to speed with upstream advances Avoiding contamination with effective site policies and cleaning validation measures
December 12-13, 2016
Park Plaza Victoria, London, Non-U.S., United Kingdom
Following the fruitful discussions in 2015, SMi's annual Cold Chain Distribution conference will bring back lively debates and industry updates to London, offering the best platform for delegates to stay ahead of this lucrative market! Benefits of Attending:
- Hear from MHRA, PIC/S and Danish Medicines Agency on GDP updates to ensure compliance
- Insights into emerging markets for cold chain distribution potential and challenges
- Learn about the latest technologies in cold chain distribution, from temperature monitoring to packaging
- Practical case studies - how to execute the last mile distribution and what are the new strategies to implement seamless cold chain distribution?
- Evaluate your logistics planning with you 3PLs to drive operational excellence
Confirmed Speakers for 2016 Include:
- Steve Todd, Senior GDP Inspector; Chair of GDP Expert Circle, MHRA
- Andrea Gruber, Senior Manager, Special Cargo, IATA
- Didier Basseras, Vice President, Global Head of Clinical Supplies - Clinical Supply Chain, Sanofi-Aventis
- Gino Vleugels, Senior Manager EMEA Temperature Control, Johnson & Johnson
- Yoram Eshel, Senior Director, Global Transportation and Logistics, Teva Pharmaceutical
- Stephen Mitchell, Quality & Compliance Manager, Global Logistics, GSK
- Saddam Huq, QA Senior Manager, Global Logistics & Cold Chain, GSK Biologicals
- Thomas Vestergaard Pedersen, Medicines Inspector, Danish Medicines Agency
- Tony Wright, CEO, Exelsius
- David Spillett, Business Development Manager, World Courier
- Fredrik Wildtgrube, Head of Global Sales, Finnair Cargo
- Tim Holliday, Qualified Person, PCI Pharma Services
- Mark Edwards, Managing Director, Modalis
and many more.
December 12-13, 2016
Four Points by Sheraton Bur Dubai, Dubai, Non-U.S., United Arab Emirates
This course will offer insight into the compilation of the eCTDs, share experience and best practice gained during eCTD submissions and explain the eCTD review und lifecycle process. Especially eCTD submissions in the GCC region will be addressed in detail. What you will learn - Overview of eCTD readiness at the agencies - Impact of the eCTD on regulatory processes and procedures - Practical experience of submitting an eCTD in the EU and GCC - eCTD compilation and life cycle management Document granularity and readiness Regulatory strategy facing technical issues Specifications and standards versus regions and procedures
January 17-19, 2017
Loews Royal Pacific Resort at Universal Orlando, Orlando, FL, United States
For six years now, ExL Events has brought together TMF professionals from all over the world to discuss and solve the latest issues in TMF management. Hundreds of people have attended events in our Trial Master File Series, which spans three continents, and have gone back to their organizations armed with the tools they needed to improve their overall processes. Come and hear unique case studies, panel discussions and training workshops from some of the leading TMF professionals in the industry. With the all-star cast that the 6th Trial Master File boasts, this will surely be an event you will not want to miss.
January 18-19, 2017
Holiday Inn Kensington Forum, London, Non-U.S., United Kingdom
Join us as SMi Group’s sell-out series Social Media in the Pharmaceutical Industry series returns in January 2017 for the ninth year. The two-day conference will bring together industry experts, regulatory bodies and leading pharma companies to discuss the latest trends like identifying influencers and monitoring data on a global scale. View the full agenda at http://www.social-media-pharma.com/evvnt and follow the conversation using #pharmasocialmedia on Twitter @smipharm. Communications is advancing and social media is the digital platform where global conversations are taking place. mHealth revenue is expected to reach USD 26 billion by 2017 and the number of health apps have increased exponentially, enabling consumer engagement and empowerment. Social media is not only being used to communicate, It is playing an important role in identifying trends, challenges and listening to what patients are talking about. Hear from key opinion leaders on how best to harness new technology and invaluable case studies, teaching you how to develop a robust digital strategy. With the series' biggest speaker line-up to date, this year's agenda will feature key opinion leaders and pharmaceutical companies at the cutting edge of social media innovation including MHRA, Creation Healthcare, MSD, Lundbeck, Pfizer, GE Healthcare, AbbVie, Janssen, Leo Pharma, Accenture, Digital Health and Care Alliance and more. In addition, two half-day pre-conference workshops on 17 January 2017: A: How will the rise of private messaging challenge the pharma industry? Hosted by Lundbeck B: Online influencer identification and mapping Hosted by the Conversationalist Agency Book by 30th September and save GBP 400. Book by 31st October and save GBP 200. Book by 30th November and save GBP 100. Keep up-date on Twitter @smipharm and conference hashtag #pharmasocialmedia
January 18-19, 2017
Holiday Inn Kensington Forum, London, Non-U.S., United Kingdom
SMi proudly presents the return of the 6th annual Pharmaceutical Microbiology conference to London in 2017! The microbiology market has significantly grown in recent years as the demand from end user industries increases. With this expansion and increased demand comes hurdles for the industry. SMi’s 6th annual Pharmaceutical Microbiology conference will address the complex challenge that the field is facing such as endotoxin testing, best practices in cleaning & disinfection and contamination control case studies. The comprehensive agenda will include presentations from both regulatory and industry experts sharing recent case studies and developing trends in the field of pharmaceutical microbiology. Expert speaker line-up includes: Sanofi Pharma, Bristol Myers Squibb, MHRA, Merial Sas, GSK, Shire Laboratories, Sanofi Pharma, and many more. For further information please get in touch with Matthew Apps on +44 (0) 207 827 6093 or email@example.com or visit www.pharma-microbiology.com
January 23-24, 2017
The Leela Mumbai Andheri Kurla Road, Sahar Village, Andheri-Kurla Road, Mumbai, Maharashtra 400059, Mumbai, CA, United States
Overview: Quality control and related contract laboratories are considered at high risk because after testing and approval, drug products and Active Pharmaceutical Ingredients (APIs) are released to the market without further check. That's the reason why the FDA and other agencies put highest emphasis on inspections of QC laboratories. Even though cGMP regulations have been in place since long time, the large number of QC related 483's and warning letters demonstrate that companies have problems with implementation. This two day interactive in-person seminar will provide participants the regulatory background and guidelines through all critical areas of GMP compliance. This course helps attendees understand the latest requirements and also provides them templates and examples to develop inspection ready documentation. Practical examples and interactive exercises will be dispersed into and between the presentations while 50% of the total time will be dedicated to practical sessions. During the seminar, participants will work in small groups on case studies and prepare the answers using prepared fill-in templates. After the course a large variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what they have learned from the course. Learning Objectives: • Learn about the regulatory background and GMP requirements for quality control and contract laboratories. • Understand and be able to explain your company's quality plan or laboratory compliance master plan. • Understand the difference between GMP and non-GMP laboratories. • Learn how to develop inspection ready documentation. • Be able to train others in your organization on GMP requirements. • Learn how to avoid and/or respond to the FDA inspectional observations and warning letters. Complimentary Hand-outs: For easy implementation, attendees will receive free access to "Laboratory Compliance Package" as Web download. This package includes 46 SOPs, a compliance master plan, checklist and templates that help to implement GMP requirements in laboratories • 50-Page primer: FDA GMP Compliance in Analytical Laboratories • Laboratory Compliance Master Plan • Worksheet - Laboratory Audits • Following Standard Operating Procedures: Agenda: Day 1 Schedule: Lecture 1: FDA Regulations and Requirements Overview • FDA 21 CFR Part 211 and 21 CFR Part 11 • Most frequently cited FDA 483s and warning letters • Requirements overview from sampling to archiving • Quality system requirements, e.g., ICH Q10 • The concept and practice of risk based compliance Lecture 2: Planning for quality and cGMP compliance • Developing and using a validation master plan • Scope, objectives and key elements of the master plan • Developing and using FDA compliant SOPs • Using templates to generate inspection ready documentation • Planning for efficiency cost-effectiveness Lecture 3: Calibration and Qualification of Laboratory Equipment • FDA requirements • USP chapter for instrument qualification • Going through examples for qualification steps(DQ, IQ, OQ, PQ) • SOPs and deliverables for three instrument categories • Developing calibration and qualification protocols Lecture 4: Equipment Maintenance and Change control • Preventive maintenance; tasks, documentation • Planned and unplanned changes • Changing hardware, firmware, documentation • Definition and handling of like-for-like changes. • Requalification: time and event based Lecture 5: Validation of Laboratory Computer Systems • Going through the new GAMP® guide: "A Risk based Approach to Laboratory Computerized Systems" • Going through a complete laboratory computer system validation from beginning to end • Integration the GAMP® guide with USP • Periodic evaluation to reduce revalidation efforts • Revalidation: why, what, when Lecture 6: Validation of Analytical Methods and Procedures • Parameters and tests according to ICH Q2 • Developing a validation plan, protocols and a report • Setting acceptance criteria for different applications • Verification of compendia methods according to USP • Transfer of analytical procedures according to the new USP Day 2 Schedule: Lecture 1: Sample Testing: Preparation, conduct, documentation • Preparing the equipment • Setting specifications and acceptance criteria • Documentation of test results • Review and approval • Not to forget: Review of electronic audit trail Lecture 2: Handling out of specification (OOS) test results • Going through the FDA OOS guide • Learning from recent FDA warning letters • Going through an OOS checklist • Using out of trend (OOT) data to avoid OOS results • Documentation and follow-up: root cause, corrective action plan, preventive action plan Lecture 3: Quality assurance of reference standards and other supplies • Supplier qualification vs. sample testing • Selection and assessment of suppliers • Retesting of materials • Preparing working standards from reference standards • Correct labeling of chemicals Lecture 4: Training for GMP compliance • FDA requirements • identification of training needs • Developing a training plan • Making GMP training interesting • Documenting effectiveness of training Lecture 5: Ensuring Integrity of Raw Data and Other records • FDA Part 11 and EU-PIC/S Annex 11 requirements • Definition of Raw Data: Electronic vs. paper • Acquisition and recording of raw data • The importance of electronic audit trail • Archiving of electronic records for 'ready retrieval' Lecture 6: Internal audits in preparation for FDA inspection • Scheduling of audits • FDA Inspections as model for laboratory audits • Going through a typical FDA laboratory inspection • Responding to Typical inspectional/audit deviation • How to avoid FDA 483s and warning letters Lecture 7: Wrap up - Final questions and answers Speaker: Dr. Ludwig Huber Chief Advisor - Global FDA compliance, Agilent Technologies • Chairman, presenter and panel discussion member at US-FDA Industry Training sessions and conferences • Served as team member of PDA's task forces "21 CFR Part 11", of US-FDA internal documents, and of the GAMP® special interest group on Laboratory Systems. • Presenter of the Year of the Institute for Validation and Technology • Director and chief editor of www.labcompliance.com, the global on-line resource for validation and compliance issues for laboratories. • Author of the books "Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems" Location: Mumbai, India Date: January 23rd and 24th, 2017 and Time: 9:00 AM to 6:00 PM Venue: The Leela Mumbai Address: Andheri Kurla Road, Sahar Village, Andheri-Kurla Road, Mumbai, Maharashtra 400059 Price: Register now and save ₹ 2000. (Early Bird) Until December 10, Early Bird Price: ₹ 14,000 from December 11 to January 21, Regular Price: ₹ 16,000 Registration Details: NetZealous - GlobalCompliancePanel NetZealous Services India Pvt. Ltd. Gururaya Mansion, 759 to 764, 8th Main road, J.P.Nagar, Bangalore - 560078 Karnataka, INDIA Phone: 1800 425 9409 Fax: 080-25149544 firstname.lastname@example.org http://www.globalcompliancepanel.in/ Registration Link - http://www.globalcompliancepanel.in/control/GMP-for-quality-control Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel
January 30 - February 1, 2017
Sheraton Boston Hotel, Boston, MA, United States
Commercializing Continuous Processing in Pharma 2017, is the only dedicated conference to explore the different tactics to introduce, implement and improve your existing approach. Over the last 2 years, the pharma and biotech industry has been busy investing in their manufacturing facilities to drive productivity and product quality, hoping to shorten product’s time to market. Continuous processing is the most promising candidate which will remove bottlenecks in your production.
Essentials Of USP Microbiology - Reading Between the Lines of the USP General and Information Microbiology Chapters: 2-Day In-Person Seminar
January 31 - February 1, 2017
Venue to be announced shortly, Orlando, FL, United States
Course Description: The objective of this two day "Essentials of USP Microbiology" seminar is to explore USP General and General Information Chapters to learn which are available and to confirm that those that you are using are being used correctly. USP documents that will be reviewed include USP and others. Various team exercises will be conducted to allow the participants to use these USP documents to solve "real life" problems. Plan to bring a cross-functional group of your personnel to attend this invaluable two day seminar.
February 1-2, 2017
Sheraton Fisherman’s Wharf, San Francisco, CA, United States
Advanced Analytics for Clinical Data 2017 brings together the leading experts in clinical data science, clinical innovation and clinical data management from major pharmaceutical and biotechnology companies. This meeting focuses on how to effectively implement big data analytics and data-driven methodologies in your clinical research.
February 1-2, 2017
Hilton Parsippany Hotel, Parsippany, NJ, United States
The Pharma Market Research Conference offers an in-depth look at the future of pharmaceutical market research presented by internationally renowned speakers in first-class sessions. We bring together the top thought leaders in pharmaceutical, biotechnology, medical device, and diagnostics to create an environment of new ideas, connections and perspectives. Your VIP access includes valuable face time with other key decision makers, learning about the most crucial issues facing today’s market research community, and taking advantage of a world-class line up of speakers and panelists offering their unique insights and expertise on the topics you care about most. The Pharma Market Research Conference is widely attended by a large variety of professionals from large, medium-sized, and emerging pharmaceutical, biotechnology, medical device, and diagnostics companies. Market Research/Marketing Research Global Marketing/Marketing Brand Management/Product Management Strategic Planning/Business Planning Business Research Qualitative Research/Quantitative Research New Products/Product Planning and Analysis Business Intelligence/Competitive Intelligence Customer Insights Knowledge/Information Management Industrial Research/Information Customer-Scientific-Medical Research/Information Emarketing/eBusiness/eDetailing Business Development/Marketing and Sales
February 6-9, 2017
Renaissance Orlando at SeaWorld, Orlando, FL, United States
How will disruptive technologies change existing products and plants? How will open source solutions impact traditional software and automation domains? Is digitalization a threat to cybersecurity and, if so, how can the risk be mitigated? How ‘smart’ are smart machines, and what benefit will these bring? How do Big Data and predictive and prescriptive analytics enable operational change? How do connected products create opportunities in aftermarket services? What software capabilities are needed to achieve transformational change? Which industries are already changing? What steps can organizations take to foster innovative thinking? Join us at the 21st annual ARC Industry Forum in Orlando, Florida to learn more about how the digital enterprise will be realized and the benefits that this can bring. Discover what your peers are doing today and what steps they are taking in their respective journeys.
February 7-8, 2017
Catalonia Plaza Barcelona Hotel, Barcelona, Non-U.S., Spain
The event unites senior executives from the generic and biosimilar industry to provide fresh insights future market trends, innovative commercial strategies and opportunities for growth for affordable medicines. Through a mixture of plenary keynote sessions, roundtables, focused work streams, the event will address a comprehensive range of key topics, including: Making medicines affordable CEO Panel Building scale and market share Mature and emerging market review Payers perspective and pricing trends Biosimilar development challenges Pharmacovogilance and post launch safety monitoring Clinical development strategies Developments in global intellectual property Regulatory strategy for generics and biosimilars How is the health policy landscape supporting affordable medicines? How to develop an integrated approach to biosimilar development and commercialization
February 8-9, 2017
HILTON SAN DIEGO/DEL MAR, San Diego, CA, United States
People in Life Sciences Summit is a talent management conference designed to address the recruitment, development and retention issues unique to managing talent within the medical device, pharmaceuticals, and biotechnology industries.
February 13-15, 2017
JW Marriott Orlando Grande Lakes, Orlando, FL, United States
Welcome to the GPhA 2017 Annual Meeting! Each year, nearly 700 attendees gather to gain insight on how the nation's most critical health and regulatory issues will impact the generic industry and the consumers who benefit from access to affordable medicines.
Our meeting attracts leading speakers from around the globe who will leave attendees with a comprehensive understanding of the opportunities and challenges for the generic pharmaceutical sector in 2017. This lineup – combined with unparalleled networking opportunities – makes GPhA's Annual Meeting the generic industry event of the year.
GPhA’s Annual Business Exposition offers a highly interactive and professional business environment in which industry vendors can meet generic industry executives. Building on the success of prior years, we offer our exhibitors abundant networking time with industry decision-makers by hosting breakfasts and breaks in the Expo ballroom as well as an Exhibit Hall Meet and Greet on Monday prior to the Welcome Reception. And the Tuesday afternoon GPhA Business Expo Reception has proven to be a highly profitable time for our exhibitors. Register Today!
February 15-16, 2017
Singapore, Singapore, Non-U.S., Singapore
Biologistics World Asia will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products. Bioplogistics World Asia 2017 will be attended by decision makers from regional and international biopharmaceuticals and biotechnology firms, top CMOs and CROs, government organizations and key global and Asian regulators. It’s your one stop solution to reach out to Asia’s logistics and supply chain industry!
February 15-16, 2017
Seoul, Korea, Seoul, Non-U.S., Korea South
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines.The programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
February 21-22, 2017
Manchester Central Convention Complex, Manchester, Non-U.S., United Kingdom
Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia. In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics. Sponsored by over 50 international leading solution provider companies, the two-day congress highlights formal or informal discussions and pre-organised 1-2-1 meetings For the latest updates to the programme, our complimentary webinars, and attendance opportunities, please visit our website at www.biomarkers-congress.com.
February 21-22, 2017
Sofitel Munich Bayerpost, München, Non-U.S., Germany
In 2017 we are combining the Cell Culture World Congress and the Downstream Processing World Congress, to bring you the Cell Culture and Downstream World Congress 2017, an all-encompassing event covering the whole manufacture and bioprocess life cycle. We are also introducing our new Formulation, Fill and Finish stream, where we look to cover important issues such as formulating high concentration biologics, freeze-drying for stability and longevity, novel filling technologies and a lot more. Across the event we will be showcasing exciting new technologies such as CRISPR gene editing, 3D printing of bioreactors and new methods of vaccine production. Content will include cutting edge research and even more case studies, over 70 presentations from those working in manufacture, bioprocess and formulation, fill and finish in big pharma and interactive sessions with biotechs.
February 22-23, 2017
Copthorne Tara Hotel, London, Non-U.S., United Kingdom
Following the success of the sell-out Cell Based Assay series, SMi Group is delighted to launch its inaugural conference on 3D Cell Culture which takes place on the 22nd and 23rd of February 2017 in London. The event is designed to address current and emerging applications of 3D cell culture, providing a platform for industry experts and clinical specialists within drug discovery, toxicology, stem cells, disease modelling and emerging technologies, to discuss the challenges and future directions of this technique. With a focus on clinical successes and emerging technologies, the conference will showcase how 3D Cell Culture has revolutionised drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem cell research and regenerative medicine. The event will also highlight exciting opportunities and latest innovations, spheroid and organoid techniques, as well as key developments in 3D and 4D bio-printing, microfluidics, CRISPR and the ongoing debate of 2D vs 3D cell culture. EXPERT SPEAKERS INCLUDE: # Stefan Przyborski, Professor of Cell Technology, University of Durham # Louisse Bisset, Senior Biologicals Quality Assessor, MHRA # Oliver Chao, Head of Emerging Biomedical Sciences, Sanofi-Aventis # Rasdoslaw Polanski, Senior Research Scientist, AstraZeneca # Robert Vries, Managing Director, Hubrecht Organoid Technology Foundations # Olaf Galuba, Scientist, Novartis # Christopher Schofield, Investigator, GlaxoSmithKline and more! For more information and to register, visit www.3D-cellculture.com/evvnt
February 27 - March 2, 2017
Bethesda North Marriott, North Bethesda, MD, United States
Advanced Manufacturing Science… Emerging Technologies to Modernize Pharmaceutical/Biopharmaceutical Development and Manufacturing IFPAC continues to set precedence as a forum for insightful discussions bringing you the latest trends and real-life applications in the field for the pharmaceutical, biotechnology, generic, food, and other related industries.
IFPAC creates a unique platform to network and discuss the latest trends and technologies with industry, academic, and regulatory leaders. Join your colleagues for the latest developments in RTRT, continuous manufacturing, process validation, risk management, lifecycle management, models & model maintenance, ICH Q12/established conditions, bio-manufacturing/bio-processing, international harmonization, emerging & innovative technologies, control strategies, various analytical techniques, and more.
You will not want to miss out on the high quality presentations and opportunities for networking. Exhibition opportunities are also available. Register Today! www.IFPACglobal.org
February 27 - March 3, 2017
Holiday Inn London Kensington Forum, 97 Cromwell Road, SW7 4DN, London, Non-U.S., United Kingdom
This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance. What you will learn - Definitions and Methods in Pharmacovigilance - Regulatory Aspects in Pharmacovigilance and Practial Examples - Diagnosis of Adverse Drug Reactions - Signal Detection and Signal Management - Modern Technologies and Social Media - Risk Management
March 5-9, 2017
McCormick Place, Chicago, IL, United States
Pittcon 2017 will be held March 5-9, 2017, in Chicago, Illinois, at McCormick Place West. Pittcon offers a unique, once a year opportunity to get a hands-on look at product innovations from leading companies and to learn the latest techniques from world-renowned members of the scientific community. Find solutions to all your laboratory challenges.
March 14-16, 2017
CCIB, Barcelona, Non-U.S., Spain
15th Annual eyeforpharma Barcelona 2016 is Europe’s largest commercial pharma meeting of 1000+ industry leaders focused on commercial innovation, engagement strategy, patient centricity and stakeholder collaboration. 1000+ delegates, 80+ senior level speakers, 3 tracks: http://goo.gl/2929t3 Speakers Include: Gregory Behar, CEO, Nestle Health Science Richard Francis, CEO, Sandoz David Ricks, President Lilly Bio Medicines, Lilly Why Barcelona? Collaborative setting: In 2017, our aim is to ensure your key stakeholders are present to advance partnerships with healthcare, technology, patients and patient associations An inspiring agenda: As you undergo a commercial evolution we will provide 3 targeted tracks, intimate workshops and stakeholder sessions to help direct your journey 1000+ in attendance: If you are looking for one commercial meeting to attend in 2017, Barcelona will be sure to give you the most senior networking opportunity possible For more information visit: http://goo.gl/2929t3
March 20-23, 2017
New York City, NY, United States
DCAT Week is the premier business development event for companies engaged in and supporting pharmaceutical development and manufacturing. Its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities. It is organized by the Drug, Chemical & Associated Technologies Association (DCAT).
March 21-23, 2017
Javits Center, New York, NY, United States
At INTERPHEX, find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Product. INTERPHEX is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by Parenteral Drug Association (PDA). Dedicated to Innovation, Technologies and Knowledge, the show focuses on the entire product development life cycle. Held in New York City, it brings over 10,000 global industry professionals together with 600+ suppliers through a unique combination of our no cost technical conference, exhibits, demonstrations, workshops, partnering opportunities, and networking events. . INTERPHEX offers annual national and international industry events and educational opportunities around the world. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. IPX Blog continues the learning beyond the show floor. For more information, visit www.INTERPHEX.com.
April 3-6, 2017
McCormick Place, Chicago, IL, United States
Automate showcases the full spectrum of automation technologies and solutions. From traditional industrial applications to cutting edge new technologies, you'll find ways to automate every process in your company.
April 10-12, 2017
The Grand Hyatt, Washington, DC, United States
With new vaccine formulations and technology platforms, vaccine developers need to have the right processes in place to manufacture them during clinical trials and at commercial scale. Use this opportunity to meet with the manufacture and bioprocessing leads who need services for all of the latest manufacturing challenges, from formulating and manufacturing adjuvants, mRNA platforms, VLPs and viral vectors, to technology transfer and continuous manufacturing. Bioprocessing and Manufacturing Conference 2017 is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture. Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges. For more information and to register, please visit http://goo.gl/Wsi2bO
April 10-12, 2017
The Grand Hyatt, 1000 H Street NW, 20001, Washington, DC, United States
This event will tackle the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. Ensure you use this event to make people aware of your expertise around key topics such as universal and seasonal flu, maternal immunization and pandemic preparedness. Influenza and Respiratory Vaccine Conference is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture. Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges. For more information and to register, please visit http://goo.gl/GirnRV
April 19-23, 2017
RAI Amsterdam, Amsterdam, Non-U.S., Netherlands
Anyone interested in hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging should attend. Specialists share recent data, present studies, and findings, and discuss the hottest topics on liver disease. The annual Congress attracts in excess of 10,000 delegates and 250 media representatives from all over the world making this a truly international networking opportunity!
April 24-25, 2017
Novotel London West, London, Non-U.S., United Kingdom
Oxford Global is proud to present our 10th Annual Proteins and Antibodies Congress. In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 50 speakers will present a full conference programme covering the topics outlined below. These topics have been compiled as a result of a comprehensive research process undertaken with an expert advisory board with members including Executive Directors and Professors from global pharmaceutical organisations and leading research institutions. Delegates will also have the opportunity to attend our co-located inaugural Biotherapeutics Congress. The congress will cover 5 interactive streams: Advances in Protein Engineering, Design & Selection; Updates in antibody structure and dynamics; Cloning, Expression, Purification & Analytics; Antibody Biotherapeutics and Protein Biotherapeutics.
April 24-25, 2017
To be confirmed, London, Non-U.S., United Kingdom
Oxford Global Conferences are proud to announce the 4th Annual Peptides Congress, taking place on 24 – 25 April 2017 in London, UK. This highly anticipated conference provides a unique opportunity for over 400 senior-level delegates to engage in scientific discussions about the current research results and latest advancements that help the industry going forward.Over 25 presentations and case studies focusing on the key advancements in peptides technologies, chemistry, formulation & delivery as well as peptide therapeutics Two-day interactive conference addressing three main themes: - Recent Progress in Peptide Technologies & Manufacturing - Peptide Discovery & Development: Peptide Chemistry, Formulation & Delivery - Advances in Peptide Therapeutics Co-located with the 10th Annual Proteins & Antibodies Congress, the event will have 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities The 2017 Peptides Congress features a revamped conference agenda that will focus on peptide technologies & manufacturing as well as peptide chemistry, formulation & delivery on Day 1. Stream 1 will feature presentations covering recent progress in peptide synthesis, advancements in peptide screening as well as updates in peptide stabilisation and efficient manufacturing of peptides. In Stream 2 our highly acknowledged speakers will focus on such hot topic areas as utilising macrocyclic peptides in drug discovery, novel strategies for peptide formulation and devices for the effective delivery of peptides. The areas of enhancing the immunogenicity of peptides as well as peptide analysis & quantification will also be addressed. Day 2 of the event will focus on peptide therapeutics. Novel case studies from exciting research areas such as diabetes, metabolic diseases and well as abdominal pain disorders will be covered. Renowned experts will also deliver talks on peptide drug conjugates, peptide-based vaccines and immunotherapies.
April 25-26, 2017
To be confirmed, London, Non-U.S., United Kingdom
Oxford Global is proud to present its Inaugural Precision Medicine Congress, on the 25th & 26th of April 2017 in London. Over two days our event will bring together 300 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. The conference programme will consist of 2 interactive streams covering: - Precision Medicine and Diagnostics in Discovery and Clinical Development - Precision Medicine and Genomics Across the two-day event, our expert panel will offer a comprehensive look at critical advances in diagnostic and genomic research. We will also be hosting key biotech solution providers, giving attendees the chance to hear about the very latest state-of-the-art technologies including NGS and rapid Biomarker analysis platforms. The meeting will cover the discovery of diagnostic developments in therapeutic areas. And how to understand the current issues in precision medicine and genomics. The event will be co-located with our Inaugural Advances in Companion Diagnostics Congress. For more information on how to register for the meeting please contact email@example.com.
April 25-26, 2017
TBC, London, Non-U.S., United Kingdom
Oxford Global Conferences are proud to present the Inaugural Advances in Companion Diagnostics Congress, taking place on the 25-26 April 2017 in London. Over two days our event will bring together 300 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of companion diagnostics. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. Companion diagnostics are laboratory tests and test kits used to determine the suitability of patients for tailored or targeted forms of therapy, e.g., therapies that act on unique biochemical pathways or that require specific genotypes or mutations. Diagnostics are used to assist in the identification of genetic mutations with implications regarding health and treatment decisions. Genetic testing has become an important piece of the continuously evolving health-care model. It is now possible to identify diseases before symptoms appear, predict the likelihood of disease development, and implement lifestyle or therapeutic interventions that will reduce or eliminate the effects of disease. Closer investigation into the nature of disease has sometimes revealed a more complex set of interactions than what was previously understood. While human DNA has similarities, there are also many individual differences. On day one our esteemed speakers will discuss the progress of diagnostic development in therapeutic areas. There will be a whole stream dedicated to exploring the opportunities and challenges of diagnostic development, including the regulatory issues surround the tests, and a number of clinical case studies with a focus on biomarkers, exosome markers and glycol-biology. Day one will also focus on the current issues surrounding imaging, with a wide range of talks focussing on different imaging technologies such as digital PCR and personalised molecular imaging. On day two the event will move more toward the advances in molecular diagnostics, with an analysis of how MDx is being applied to key areas such as auto-immune disease and oncology. We will also hear from experts discussing the use the liquid biopsy and the quest to make it more efficient. You will have the opportunity to hear from key figures as to how CDx is being used in new and exciting therapeutic areas such as primary care, rare disease and neuroscience. The conference will also focus on how CDx is being used in collaboration with NGS technologies. For more information please contact Danielle: firstname.lastname@example.org
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation): 2-Day Workshop
May 15-16, 2017
Venue to be announced shortly, Boston, MA, United States
Course Description: The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs).
This two day, interactive Seminar which provides a conduit to enhance your understanding of the Continued Process Verification, will be reviewed in detail: where does it begin; what is included; and, when does it end. Common questions asked by the users of Process Validation include; How does one integrate these two different concepts (Phase 1, 2, and 3 vs. Stages 1, 2, and 3) and where do they merge? Do they exist independently of each other or do they complement each other to enhance, build and provide a product that neither alone could. Questions that may arise include where are cGMPs initiated? To what extent must they be used? Since Stage 3 extends through commercial batch manufacturing, what happens to Phase 3? Does it follow along or with Stage 3? Questions that exist include how one manages special situations to include viral inactivation and removal, impurity clearance, process consistency, process solution stability, endotoxin, bioburden, and other miscellaneous cell culture tests to include DNA and host cell protein. These questions will be addressed within Stage 2 as presented here and include utilization of Process Validation and Phase 1, 2 and 3, where their Guidances blend and where they remain distinct. In particular, Stage 3. Important: Please plan to bring a multidisciplinary group from your Company to gain the most from this very important seminar.
May 15-16, 2017
Copthorne Tara Hotel, London, Non-U.S., United Kingdom
Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology Congress, taking place 15-16 May 2017 in London UK. The event features 200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. 36 presentations and case studies will focus on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling. The congress has 4 interactive streams: • Discovery of Immuno-Oncology Therapies • Pre-clinical Immuno-Oncology • Screening, Assays and Modelling in Immuno-Oncology • Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
May 15-16, 2017
Berlin, Non-U.S., Germany
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)
May 16-17, 2017
Venue to be announced shortly, Philadelphia, PA, United States
This interactive one-and-a-half-day seminar is intended to educate regulatory and quality professionals regarding the rather complicated regulations that distinguish Non-prescription Drugs from other products such as foods, cosmetics, dietary supplements and prescription drugs that sometimes contain the same ingredients. Recent FDA actions such as the banning of antibacterial soaps and ongoing programs that may impact manufacturers and private label distributors will be discussed. It will explain differences in the way homeopathic and conventional drugs are regulated and update participants on FDA’s application of GMP regulations to manufacturing low risk drugs that could be sold as cosmetics with the same ingredients, but different labeling.
May 16-18, 2017
Pennsylvania Convention Center , Philadelphia, PA, United States
CPhI North America will be the epicenter of pharmaceutical innovation, emerging trends, insights, and community-building connections in North America. It will bring together those seeking powerful partnerships to illuminate the path towards high growth in this ever-evolving industry. The inaugural event will take place on May 16–18, 2017, at the Pennsylvania Convention Center in Philadelphia, PA, adjacent to InformEx, the home of fine and specialty chemicals. Pharmaceutical executives along with R&D, compliance, regulatory, manufacturing, QA/QC, supply chain, packaging, and procurement professionals will gather to build connections to capitalize on emerging trends, further innovation, and tackle industry challenges. The launch of CPhI North America has been strategically timed to take advantage of strong industry growth and innovation while addressing the ever-increasing challenges to the future prosperity of the industry. CPhI North America has been expressly designed to serve the full pharmaceutical value chain. The exhibit floor will be zoned to facilitate a more intimate and efficient experience allowing attendees to customize their experiences. -iCSE: The Drug Development zone will highlight world-class CROs and other organizations serving drug developers. -CPhI North America: The Manufacturing Ingredients zone will consist of active product ingredients (API) and excipient leaders. -FDF: The Finished Drug Products zone will feature leading small and large molecule CDMO/CMOs. -InnoPack: The Packaging zone will showcase packaging innovation. In addition to the zoned exhibit floor populated with leading industry organizations and solutions, CPhI North America will include the following opportunities: -Innovation Zones: These zones will presenting cutting-edge technology, products, and approaches. The zones will allow industry professionals to gather to network and discuss innovations and challenges of common interest and mutual benefit. -Networking Sessions: These events will bring the industry at large together, and smaller targeted events will be held for specific functions or specific areas of interest. -One-on-One Matchmaking: This opportunity will facilitate connections that accomplish individual and organizational objectives. -World-class Educational Programming: CPhI North America has forged strategic partnerships with the American Chemical Society (ACS), the largest scientific association in the world, and CBI, the industry leader in actionable life sciences content and analysis. Through these partnerships, CPhI North America has created rich programming that addresses the full spectrum of the pharmaceutical value chain. The educational programming will include 24 Master Classes covering the most pressing topics within drug development, formulation, manufacturing, and outsourcing. In addition, the programming will include Regulatory Town Hall and keynote sessions with the FDA and leading global regulators.
May 16-18, 2017
Pennsylvania Convention Center, Philadelphia, PA, United States
At InformEx, leading-edge global innovation meets a dynamic community of industry leaders within the evolving fine, specialty, and custom chemicals industry. On May 16–18, 2017, a better-than-ever InformEx will be held at the Philadelphia Convention Center adjacent to CPhI North America’s debut. 340+ InformEx exhibitors and 2,500+ attendees from 30 countries will gather at this hub of fine and specialty chemical innovation. The specialty chemicals industry is changing in very meaningful ways. Chemical product innovation is now often more incremental progress rather than the blockbuster advancements of the 20th century, emerging markets are driving much of the industry’s growth, volatility in numerous end-use markets is difficult to manage, and increasing regulatory demands are creating further complexity. On the other hand, high-performance technologies, value-adding digital technologies and the demand for environmentally friendly products present tremendous opportunities. These industry-driving changes within the fine and specialty chemicals industry created the need to evolve InformEx’s 32-year legacy to meet new market demands. An Evolving Event for a Changing Industry InformEx 2017 has evolved in critical ways while drawing on the decades of experience the organization has serving the fine and specialty chemicals market. This evolution has led to dynamic conference programming, the Innovation Highway, a move to Philadelphia, and adjacency to CPhI North America. The 2017 Conference Program will foster dialogue on innovation and commercialization trends, regulatory challenges, market dynamics, and opportunities for growth within today’s rapidly growing chemical markets, including the broader energy field, personal care, life sciences, and agrochemicals. Educational sessions will highlight opportunities in new innovative sub-segments, such as green chemistry, 3-D printing, and electronic chemicals. The American Chemical Society (ACS), the largest scientific organization in the world, and The Society of Chemical Manufacturers and Affiliates (SOCMA) are serving as strategic partners to help build an outstanding 2017 conference program. InformEx 2017 will feature the Innovation Highway, which will connect InformEx and CPhI. The Innovation Highway will feature opportunities for collaboration and innovation between the specialty chemical and pharmaceutical industries.
May 22-23, 2017
Capthone Tara Hotel , London , Non-U.S., United Kingdom
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions
May 29-30, 2017
Austria Trend Hotel Savoyen, Vienna, Non-U.S., Austria
Vienna calling! Pharma Business Development Insiders choose Vienna as one of the best summer venues for the 64th euroPLX Partnering Conference. Seeking and offering business opportunities is what the 64th euroPLX international pharma partnering conference is all about. Once again it will be attended by pharma business development key players. It is the preferred business platform for business development decision makers of more than 1,500 pharma and biotech companies from 81 countries worldwide since more than 21 years: CEOs, owners, vice presidents, directors, and BDandL managers of drug developing, producing, or marketing and distribution companies. For sponsorship opportunities please download the Sponsorship Opportunites Flyer (PDF) from the euroPLX 64 Vienna page or contact us.
June 24-27, 2017
CLARION CONGRESS HOTEL PRAGUE, Freyova 33 - 190 00, Prague, Non-U.S., Czech Republic
The main focus of EACPT 2017 is the role of clinical pharmacology in personalized pharmacotherapy, both a priori – pharmacogenetics – and a posteriori (therapeutic drug monitoring). The topic list includes a broad spectrum of topics that relate to Clinical Pharmacology: - Access to medicines. Innovation and sustainability of National Health Systems - Cardiovascular pharmacology and diabetes - Clinical toxicology - Clinical trials methodology - Drug development and regulatory sciences - Drug Safety and pharmacovigilance - Education - Global Health - Research Ethics - Pharmacoeconomics and health technology assessments - Inflammatory and immune based diseases and treatments - Infectious diseases. Antibiotics, antivirals, antifungals. - Neuro-psychopharmacology - Oncology - Orphan medicines - Research using Electronic Health Records. - Pharmacology of pain - Pharmacogenetics and pharmacogenomics - Pharmacokinetics, TDM, PK-PD modelling and drug interactions - Special populations
June 27-27, 2017
Hyatt Regency Hotel, New Brunswick, NJ, United States
DCAT Sharp Sourcing 2017 is a conference and networking event that provides peer and customer insight on the best practices and practical ways for optimizing pharmaceutical manufacturing and supply networks. The event is designed for senior to mid-level executives engaged in sourcing, procurement, supply management, and external manufacturing and their business counterparts on the supply side. It is organized by the Drug, Chemical & Associated Technologies Association (DCAT).
June 29 - July 1, 2017
Melia Valencia , Valencia , Non-U.S., Spain
Recommended: Pharma Conferences |Pharmaceutical Conferences | Pharmacy Conferences Magnus Group invites all the participants to World Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2017) which is going to be held during June 29- July 01, 2017 at Valencia, Spain. The (PDDS 2017) World Conference on Pharmaceutics and Drug Delivery Systems will bring together a collection of investigators who are at the forefront of their field, and will provide opportunities for junior scientists and graduate students to interactively present their work and exchange ideas with established senior scientists. At Congress, you’ll learn the latest developments in Drug Delivery Systems in sessions led by renowned scientists across the globe. Plus, you’ll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You’ll leave better educated and more invigorated than you thought possible. We wish to see you in Valencia, Spain. Recommended: Pharma Conferences |Pharmaceutical Conferences | Pharmacy Conferences
September 25-27, 2017
Hilton Atlanta Airport, 1031 Virginia Ave, Atlanta, GA, United States
Mass Spectrometry 2017 is a unique opportunity to discuss best practices within the laboratory research and those in other industries if the people are doing related things getting a variety of viewpoints can help us see where we can change or improve our own ideas and processes. Mass Spectrometry 2017 conference designed in all aspects of application including electrospray ionization and mass spectrometry imaging. There will be many seminars, workshops and technical sessions take place which will catch the attention of the professionals to attend Mass Spectrometry conference and it would enormously enrich our knowledge in understanding the current requirements of the global pharmaceutical industry and LCMS/GCMS.
November 28-29, 2017
Sandton Convention Centre, 161 Maude Street, Sandton, Non-U.S., South Africa
Saphex is rapidly establishing itself as the most strategic industry event in the South African region that brings together all major stakeholders – industry leaders, policy-makers, regulators, academics, investors, scientists and patient representatives, to tackle the most pressing issues the industry is facing. With over 2000 visitors expected at Saphex 2017, there will be ample opportunity for you to connect and establish relationships with fellow professionals from the pharmaceutical industry. We are also anticipating over 130 exhibitors and over 100 countries represented at the event. The event will incorporate an exhibition and a conference, delivering business contacts and forging strategic alliances in combination with the knowledge and information that you will need to win in the South African pharmaceutical sector. Saphex will be held under the theme, 'Continuing development of the South African Pharmaceutical Industry: Forging ideas for the future composition of the sector'. Aiming to explore the current composition of the industry in South Africa, and inviting several experts in their respective fields to give their opinion on where the future of the market may lead. The approach that companies pursue will hinge upon their individual goals. Inevitably companies will need to decide how to satisfy contending stakeholder demands while pursuing sustainable growth in a competitive market.